Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Cancer Genomics and Diagnostics, and Neuroendocrine Tumor Research Advances.
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Abstract A010: Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth
<scp>KRAS</scp>/<scp>GNAS</scp>‐testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound‐guided workup of suspected mucinous neoplasms of the pancreas
Epithelial-to-Mesenchymal Transition in Pancreatic Cancer is associated with Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging
Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma
The Outcome of <i>Ex Vivo</i> TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic <i>In Vitro</i> Growth Capacity between T-Cell Clones
Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis
Diffusion Kurtosis Imaging—A Superior Approach to Assess Tumor–Stroma Ratio in Pancreatic Ductal Adenocarcinoma
The Microarchitecture of Pancreatic Cancer as Measured by Diffusion-Weighted Magnetic Resonance Imaging Is Altered by T Cells with a Tumor Promoting Th17 Phenotype
Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor Hypoxia
Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasms
Germline <i>BRCA2</i> K3326X and <i>CHEK2</i> I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer
Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic Cancer
The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment
Antimicrobial Peptide Human Neutrophil Peptide 1 as a Potential Link Between Chronic Inflammation and Ductal Adenocarcinoma of the Pancreas
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability
Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts
The bile acid receptor FXR attenuates acinar cell autophagy in chronic pancreatitis
Upregulation of cell cycle genes in head and neck cancer patients may be antagonized by erufosine’s down regulation of cell cycle processes in OSCC cells
<i>HYAL2</i> methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma
Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas
Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors
Abstract IA46: Towards implementation of T-cell therapy in pancreatic cancer
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis